Literature DB >> 2437918

A Mr = 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the c-erbB-2 gene.

T Kadowaki, M Kasuga, K Tobe, F Takaku, E Nishida, H Sakai, S Koyasu, I Yahara, K Toyoshima, T Yamamoto.   

Abstract

In human epidermoid carcinoma KB cells, a glycoprotein of Mr = 190,000 (gp190) has been shown to be phosphorylated on tyrosine residues upon EGF stimulation (Kadowaki et al., 1987, J. Biol. Chem. in press). Using a specific antibody to the c-terminal portion of the human c-erbB-2 gene product, we have found that gp190 is the human c-erbB-2 gene product which is structurally closely related to the epidermal growth factor (EGF) receptor. Since monoclonal antibody specific for the EGF receptor abolished both EGF binding to its receptor and tyrosine phosphorylation of the c-erbB-2 gene product, we have concluded that activation of EGF receptor tyrosine kinase activity upon EGF binding leads to the phosphorylation of the c-erbB-2 gene product on its tyrosine residues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437918     DOI: 10.1016/s0006-291x(87)80021-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

Authors:  R J Epstein; B J Druker; T M Roberts; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.

Authors:  T Akiyama; S Matsuda; Y Namba; T Saito; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.

Authors:  Y Kokai; K Dobashi; D B Weiner; J N Myers; P C Nowell; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells.

Authors:  T Akiyama; T Saito; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

5.  Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.

Authors:  C R King; I Borrello; F Bellot; P Comoglio; J Schlessinger
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

6.  Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

Authors:  R Aasland; J R Lillehaug; R Male; O Jøsendal; J E Varhaug; K Kleppe
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

7.  Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers.

Authors:  S Kobayashi; H Iwase; Y Itoh; H Fukuoka; H Yamashita; T Kuzushima; H Iwata; A Masaoka; N Kimura
Journal:  Jpn J Cancer Res       Date:  1992-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.